Vascular access is the Achilles' heel of hemodialysis. Current vascular access approaches for hemodialysis include arteriovenous (AV) fistula, AV graft, and central venous catheter. Strengths and weaknesses of each access type are described. New technology and procedures in introducing an access, monitoring access function, and salvaging a non-functioning access are also described. (Int J Artif Organs 2008; 31: 382-5) 
PAST Hemodialysis requires adequate blood flow delivery to the dialyzer for correction of volume, waste product and electrolyte dislocations. Vascular access reflects the evolution of available resources and changing technology. The Scribner shunt provided the first AV access (1) . Although this shunt was able to provide access to blood without venipuncture and could be used immediately after placement, it was plagued with problems of instability, infection and thrombosis. Moreover, this access required an end-to-end anastomosis with the connecting tubings exposed externally.
PRESENT
For acute dialysis, the insertion of Shaldon dialysis catheters into femoral veins and the introduction of catheters into an internal jugular vein are frequently practiced today (2, 3) .
AV fistulas and grafts have become the access of choice for over four decades (4, 5) . Side-to-side anastomosis of native vessels has diminished: (a) the incidence of arterial insufficiency distally, which can bring about complications such as the steal syndrome, and (b) the incidence of venous stasis that can lead to edema. An AV fistula has a high primary non-functioning rate of approximately 20% to 50%. Factors that have been proposed to identify the primary failures of AV fistulas include obesity, diabetes mellitus, female sex, the absence of pre-operative vein mapping, older age, white race, low blood pressure, presence of either peripheral or coronary artery disease, the skill of the surgeon, late referral to a nephrologist, poor venous distensibility, and very small vessel size (6) (7) (8) (9) (10) . A high patency rate and a low infection rate combine to make AV fistula the access of choice. An AV fistula requires minimal intervention once it reaches maturation. However, it takes a long time (usually months) for an AV fistula to mature after creation.
An AV graft is often fashioned when native vessels are not large enough to make it feasible to construct an AV fistula. An AV graft can be used within a few weeks after placement. The infection rate for an AV graft is higher due to the presence of foreign materials. Endothelial and fibromuscular hyperplasia of the vein often leads to stenosis. Stenosis at the vein-graft anastomosis results in the complications of recirculation and thrombosis. Thrombosis accounts for approximately 80% of graft failures. The salvage rate of clotted grafts after declotting measures is worse than the salvage rate of stenotic but still patent grafts after the performance of elective angioplasty.
Inserted into an internal jugular vein, a tunneled catheter is used when an access is needed emergently, temporarily, or when peripheral vessels are not available for AV fistula or graft construction. Infection and thrombosis rates are high in the case of tunneled catheters. Improvement in the access placement success rate Editorial that has occurred over the past few decades is the result of a better assessment of both the arterial and the venous systems prior to access formation. Access creation is generally avoided in the dominant upper extremity. This policy is especially important in patients administering self-dialysis, in which the dominant hand is used to introduce dialysis needles into a vascular access in the nondominant upper extremity. Central catheters inserted via peripheral or subclavian veins predispose to possible future central venous stenosis. Adequate arterial blood to the hand can be evaluated by a physical examination of the radial and ulnar pulses, the Allen test or Doppler studies. Routine arterial and venous mappings can facilitate the selection of the most appropriate vein and the best location for the access construction. At least 9 potential sites for AV fistula creation are available in the upper extremity (5), including an antecubital proximal forearm fistula, which has gained popularity (11) . A wrist radiocephalic (i.e., Brescia-Cimino) fistula placed in the non-dominant arm is the preferred approach (4). Appropriate exercise post fistula placement is encouraged to foster maturation by increasing blood flow and/or blood pressure.
Vigilant monitoring of an AV access is an ongoing process in an attempt to detect early stenosis. Vascular access stenosis leads to reduced blood flow, recirculation, thrombosis and inadequate dialysis. The most common cause of stenosis in AV grafts is myointimal hyperplasia at or just distal to the graft-vein anastomosis. Proximal stenosis occurs at previous subclavian catheter placement sites. Stenosis is suggested by an increase in intensity of the thrill or the pitch of the bruit on physical examination. Elevated venous pressure may be noted during a dialysis treatment, or prolonged bleeding from a venipuncture site may be observed after needle removal.
Current KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations of the National Kidney Foundation suggest further investigation: for grafts, (a) if an access blood flow is less than 600 ml/min or (b) if the access blood flow is less than 1,000 ml/min and has fallen by more than 25% over the preceding 4 months (12) . For fistulas, a blood flow rate less than 400-500 ml/min warrants evaluation (12) .
Commonly-used direct access flow measurement techniques include: (a) dilution of the blood by a bolus of saline during dialysis, (b) thermodilution and (c) Doppler ultrasonography (13) . Indirect measurements of access flow include intra-access pressure, static venous pressure, and dynamic venous pressure.
Once access flow compromise is suspected, confirmation may be achieved with access recirculation studies. Imaging studies with Doppler ultrasonography and venography can help identify the site of stenosis.
Correction of AV access complications are ordinarily carried out by surgeons (general, transplant or vascular), interventional radiologists and interventional nephrologists. Thrombectomy and angioplasty are outpatient procedures. Patients return to the dialysis unit usually on the same day to receive their dialysis treatments. Compromised blood flow in the central venous catheter due to thrombosis or a fibrin sheath around the catheter tip is frequently corrected in the dialysis unit with intraluminal instillation of tissue plasminogen activator. Either heparin or 4% sodium citrate (14) locks are used between treatments to maintain catheter patency. Recently, the successful use of tissue plasminogen activator as a dialysis catheter locking solution has been described (15) .
Infections associated with central venous catheters continue to be a major impediment. The frequency of catheter-related bacteremia ranges from 2 to 5.5 episodes per 1,000 catheter-days. Endocarditis, osteomyelitis, septic arthritis, epidural abscess and death are serious complications that occur in 5% to 10% of patients with catheter-related bacteremia. Minimizing catheter-related bacteremia requires aseptic technique, which includes washing hands, wearing clean gloves, and minimizing the duration of air exposure of the catheter lumen. The catheter hubs are soaked in chlorhexidine or povidone-iodine before connection and disconnection of the catheter with dialysis blood tubings. Staff members and patients should wear masks when the catheter lumen is exposed. The exit site should be cleaned and dressed. Administration of topical antibiotic decreases the frequency of catheter-related bacteremia. In combination with an anticoagulant, an antibiotic lock is a concentrated antibiotic solution that is instilled into the lumen of the dialysis catheter in an attempt to destroy the bacteria beneath the catheter's biofilm for the purpose of salvaging the catheter or providing prophylaxis (16) . The success rate of an antibiotic lock in curing catheter-related bacteremia is related to the nature of the invading microbe; 87% to 100% for gram-negative infections, 75% to 84% for S. epidermidis infections and 40% to 55% for S. aureus infections. Recently, a method of using bacteriophages to penetrate a biofilm to destroy the underlying bacteria has been suggested (unpublished data).
FUTURE
The trend in dialysis is high-intensity dialysis carried out at home or in the dialysis center in the form of long nocturnal (3-6 times weekly) or short daily (6 times weekly of 2-3 hours each session) dialysis. Patients or their caretakers are often required to cannulate the AV access themselves. Recent data show that the buttonhole technique that involves inserting the dialysis needle through the same needle tracts of an AV fistula facilitates cannulation and results in a lower degree of wear and tear to the access (17, 18) . However, the question of whether a heightened incidence of fistula infections may occur as a result of the frequent use of this technique for daily long dialysis has been raised (unpublished data). Earlier construction of an AV fistula allows adequate time for the structure to mature so as to avoid the necessity of placing a catheter on an urgent basis to provide prompt dialysis treatments (19) .
This principle of "fistula first" should be diligently observed. It is of note that a larger number of people are living into advanced ages and their susceptibility to renal failure as a result of hypertension, diabetes mellitus, urinary obstruction, old age and other problems is correspondingly becoming higher. Consequently, it has been suggested that venipunctures be avoided in veins above the wrists so that venous integrity of the larger veins can be maintained in readiness for possible future AV fistula creation (5) . In addition, when venipunctures are inevitable, it would seem prudent to allow the veins of the dominant hand to be used first before those of the nondominant hand. Underutilization of AV fistulas in women is due to vascular anatomical differences between the sexes (20, 21) . Noninvasive preoperative screening for appropriate sites and evaluation of blood flow may result in better access outcome and patency.
Allografts are available for AV access (22) . Femoral arterial allografts procured from donors were fixed with 20% formaldehyde at room temperature for 4 hours, and stored in alcohol at 4 °C until time of use. The allograft was transplanted under local anesthesia and cefazolin was administered perioperatively. Indications for this procedure included poor vascular condition of the forearm, multiple failed attempts at construction of an AV fistula, lack of availability of native vessels for vascular access creation, presence of pseudoaneurysm, or inadequate blood flow of an AV fistula. There was no evidence of acute or chronic rejection. Patency rate was 90% at 3 months, 85% at 6 months, 74% at 1 year, 53% at 2 years, and 42% at 3 years. The main complication was thrombosis (22) .
A new technique to measure vascular access flow during dialysis is based on extracorporeal temperature gradients, and their changes on reversing the extracorporeal bloodlines without having to inject an indicator into the circulation (23, 24) . Advantages of this procedure are that there is no need to inject an indicator and it takes about 9 minutes to perform, compared to 30 minutes with a thermodilution approach.
Stent and stent grafts are used to treat hemodialysis graft-related stenosis that have failed angioplasty, including angioplasty-induced venous rupture (25, 26) . The technical success rate for insertion of the device was reported to be 100%. Patency of vascular access was 81%, 70%, and 54% at month 1, 3, and 6, respectively. The primary patency of the stent or stent graft was 96%, 93%, 87% and 47% at 1, 3, 6, and 12 months, respectively. Stents and stent grafts are useful for salvaging failed angioplasty procedures.
An innovative self-centering, tunneled hemodialysis access catheter called Centros TM has recently been introduced (27) . The distal end of the catheter has a unique curved configuration. When placed in the superior vena cava, its curved tips keep the ports of the catheter centered in the superior vena cava and away from the vein walls. Compared to other catheters, the tips of the catheter are not placed in the atrium but in the lower third of the superior vena cava.
It is likely that wearable artificial kidneys will be commercially available for use in the near future (28) . The "wear and tear" and other demands (e.g., the possibility of a higher infection rate) imposed on a vascular access as a result of prolonged use will present new challenges. Finally, the development of a long-indwelling vascular access implant made from non-body material has not yet been realized. It is our hope that an innovative mind will be soon rewarded much deserved recognition for this valuable discovery! To summarize, new technologies and procedures to improve vascular access for hemodialysis do exist. Nevertheless, for the foreseeable future, vascular access will continue to be the Achilles' heel of dialysis treatments.
